Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dipexium Pharmaceuticals, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dipexium Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Dipexium Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is PLXP. The reporting company's CIK number is 1497504.
The total value of stock buying since 2005 is $656,979.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-06-14||Valentino Michael J (Executive Chairman)||Buy||29,091||6.88||200,000|
|2017-06-14||Jorden David Emerson (Acting Chief Financial Officer)||Buy||32,727||6.88||224,998|
|2017-06-14||Mossman Gary L (Chief Operating Officer)||Buy||7,273||6.88||50,001|
|2014-05-21||Dean Jack H (Director)||Buy||3,000||9.00||27,000|
|2014-03-18||Shawah Robert G. (Chief Accounting Officer)||Buy||500||12.00||6,000|
|2014-03-18||Garrett David (VP, Finance & Corp. Dev.)||Buy||2,083||12.00||24,996|
|2014-03-18||Dean Jack H (Director)||Buy||2,083||12.00||24,996|
|2014-03-18||Luci David P (President, CEO, Secretary)||Buy||2,083||12.00||24,996|
|2014-03-18||Harrison Thomas L (Director)||Buy||2,000||12.00||24,000|
|2014-03-18||Deluccia Robert J (Executive Chairman)||Buy||2,083||12.00||24,996|
|2014-03-18||Coughlin Christopher J (Director)||Buy||2,083||12.00||24,996|
Insider trading activities including stock purchases, stock sales, and option exercises of PLXP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dipexium Pharmaceuticals, Inc. (symbol PLXP, CIK number 1497504) see the Securities and Exchange Commission (SEC) website.